Rebel Compliance Law
  • Home
  • About
    • Our Services
    • Our Values
    • Rebel Compliance Law
    • Sharon R. Delshad, Esq.
  • Articles & Events
    • Industry News and Articles
    • Rebel Compliance News and Events
    • Subscribe
  • Resources
    • Members
    • Resources
    • Quarterly Updates
  • Contact
  • Privacy Policy
Select Page
OPDP Untitled Letter – Althera Pharmaceuticals (06/02/2022)

OPDP Untitled Letter – Althera Pharmaceuticals (06/02/2022)

by sd2040@sdconsulting.services | Jun 17, 2022 | Industry News

Summary: On June 2, 2022, the FDA’s Office of Prescription Drug Promotion (OPDP) issued an Untitled Letter to Althera Pharmaceuticals, Inc., for an HCP-facing promotional material about their LDL-C reducing combination statin drug, ROSZET (rosuvastatin and...

© 2022 Rebel Compliance Law, PC